The No. One Question That Everyone Working In ADHD Medication Pregnancy Must Know How To Answer
The No. One Question That Everyone Working In ADHD Medication Pregnancy Must Know How To Answer
Blog Article
ADHD Medication During Pregnancy and Breastfeeding
The choice of whether to stop or continue ADHD medications during pregnancy and breastfeeding is challenging for women with the condition. There aren't enough data on how long-term exposure may affect a foetus.
A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that further high-quality research is needed.
Risk/Benefit Analysis
Women who are pregnant and taking ADHD medications must weigh the benefits of using them against the risks to the foetus. The doctors don't have the information to give clear advice but they can provide information on the risks and benefits to help pregnant women make an informed decision.
A study published in Molecular Psychiatry found that women who were taking ADHD medications during early pregnancy did not have an increased risk of fetal heart malformations or major structural birth defects. Researchers conducted a large population-based study of case-control to determine the prevalence of major structural birth defects in infants born to mothers who took stimulants during early pregnancy and those who had not. Pediatric cardiologists, clinical geneticists and other experts examined the cases to confirm that the classification was correct and to reduce any bias.
The study of the researchers had some limitations. The most important issue was that they were unable to distinguish the effects of the medication from the effects of the underlying disorder. This limitation makes it difficult for researchers to establish whether the small associations observed among the groups exposed were due to the use of medication or if they were confounded by co-morbidities. In addition, the researchers did not study long-term offspring outcomes.
The study revealed that babies whose mothers had taken ADHD medication during pregnancy were at a slightly greater risk of being admitted to the neonatal care unit (NICU) in comparison to mothers who did not use any medication during pregnancy or had quit taking the medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.
Women who were taking stimulant ADHD medication during pregnancy were also at an elevated chance of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.
Researchers suggest that the minor risk of using ADHD medication during pregnancies in the early stages may be offset by the greater benefits to both mother and baby of continuing treatment for the woman’s disorder. Physicians should discuss this with their patients and, if possible, assist them in developing strategies for improving their coping skills that may minimize the impact of her disorder on her daily life and relationships.
Medication Interactions
Doctors are increasingly confronted with the dilemma of whether to keep treatment or stop as more women are diagnosed with ADHD. Often, these decisions are made without solid and reliable evidence either way, so physicians have to weigh their experience from their own experiences, those of other doctors, and what the research suggests about the subject and their best judgment for each patient.
The issue of possible risks to infants is difficult to determine. Many of the studies on this topic are based on observational evidence rather than controlled research, and their conclusions are often contradictory. Furthermore, most studies restrict their analysis to live births, which could underestimate severe teratogenic effects that cause abortion or termination of the pregnancy. The study that is discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.
The conclusion: While some studies have found a positive association between ADHD medications and the risk of certain birth defects, other studies have found no connection, and most studies demonstrate a neutral or slightly negative effect. In every case, a careful evaluation of the potential risks and benefits must be performed.
For many women with ADHD, the decision to discontinue medication can be difficult, if not impossible. In an article recently published in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for these patients. Furthermore, a loss of medication can affect the ability to perform jobs and drive safely, which are important aspects of a normal life for many people with ADHD.
She suggests women who are uncertain about whether to continue or stop taking medication because of their pregnancy consider the possibility of educating friends, family members, and coworkers on the condition, more info its impact on daily functioning, and on the advantages of staying on the current treatment plan. It can also make the woman feel more comfortable when she is struggling with her decision. Certain medications can be passed through the placenta. If the patient decides not to take her ADHD medication while pregnant and breastfeeding, it's important to be aware that the drug may be transferred to her infant.
Risk of Birth Defects
As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows, so do concerns about what impact the drugs might have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing information on this topic. Using two massive data sets researchers were able to examine more than 4.3 million pregnancies and see whether stimulant medication use increased the risk of birth defects. Although the risk overall remains low, the researchers did find that first-trimester exposure to ADHD medications was linked to a slightly higher rate of certain heart defects, like ventriculo-septal defects (VSD).
The researchers of the study found no association between the use of early medications and congenital abnormalities like facial clefting, or club foot. The findings are in line with previous studies showing the presence of a small, but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications before the birth of their child. The risk increased in the latter part of pregnancy, when a lot of women began to stop taking their medication.
Women who used ADHD medications in the first trimester of their pregnancies were also more likely to undergo a caesarean section, a low Apgar score following delivery, and a baby who needed breathing assistance at birth. However the researchers of the study were not able to eliminate selection bias by limiting the study to women who didn't have any other medical issues that could have contributed to these findings.
Researchers hope that their study will help doctors when they see pregnant women. The researchers suggest that while discussing benefits and risks are crucial, the decision on whether to continue or stop medication should be made in light of the severity of each woman's ADHD symptoms and her needs.
The authors warn that, while stopping the medication is an option to think about, it isn't advised because of the high incidence of depression and other mental problems for women who are pregnant or recently gave birth. Additionally, the research suggests that women who choose to stop taking their medication are more likely to experience a difficult time getting used to life without them following the baby's arrival.
Nursing
It can be a challenge becoming a mother. Women suffering from ADHD are often faced with a number of difficulties when they have to manage their symptoms, attend doctor appointments, prepare for the birth of a child and adjust to new routines. Therefore, many women choose to continue taking their ADHD medications throughout the course of pregnancy.
The majority of stimulant drugs are absorbed by breast milk in very small amounts, therefore the risk to the nursing infant is very low. The rate of medication exposure will differ based on dosage the medication is administered, its frequency and the time of the day. In addition, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk. The impact of this on a newborn is not fully known.
Due to the absence of research, some doctors may recommend stopping stimulant drugs during a woman's pregnancy. It is a difficult decision for the woman, who must weigh the advantages of taking her medication as well as the risks to the embryo. In the meantime, until more information is available, doctors may inquire about pregnant patients whether they have a history of ADHD or if they plan to take medication during the perinatal period.
A growing number of studies have shown that the majority of women are able to safely continue taking their ADHD medication during pregnancy and while breastfeeding. In response, a growing number of patients are opting to continue their medication. They have discovered after consulting with their doctors that the benefits of keeping their current medication outweigh any potential risks.
It's important for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss the medication they are taking with their physician as well as the pros and cons for continuing treatment. This includes non-pharmacological strategies. Psychoeducation should also be offered to help pregnant people with ADHD recognize their symptoms and the underlying disorder, learn about available treatment options and reinforce existing strategies for managing. This should be a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. Pregnancy counselling should include the discussion of a treatment plan for both mother and child, as well as monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.